The present invention relates to pharmaceutical compositions comprising a quinolone carboxylic acid compound and an absorption enhancer. In further embodiments, the compositions further comprise a basifer or a crystallization inhibitor, or both a basif?er and a crystallization inhibitor. These compositions are useful for treating, preventing, or reducing the risk of infection.
申请公布号
WO2010096551(A3)
申请公布日期
2010.12.16
申请号
WO2010US24576
申请日期
2010.02.18
申请人
RIB-X PHARMACEUTICALS, INC.;LI, DANPING;BURAK, ERIC, S.;DRESBACK, DAVID, S.